Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.05.022Source: DataRank Database

Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC is a research paper published in Journal of Thoracic Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 84 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access84 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 3.44)OA: bronzeTopics (38)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Vikas Ghai ORCID,Joseph M. Amann,Tamio Okimoto ORCID,Konstantin Shilo ORCID,Taek‐Kyun Kim

Live enrichment

PubMed:32565389 PMC:PMC7641981 OpenAlex:https://openalex.org/W3036505603

National Institutes of Health

Grant: R01DA040395

National Institutes of Health

Grant: R56HL133887

National Institutes of Health

Grant: U01CA213330

National Institutes of Health

Grant: U01HL126496-02

U.S. Department of Defense

Grant: W81XWH-16-1-0301

U.S. Department of Defense

Grant: W911NF-17-2-0086

NCI NIH HHS

Grant: UG1 CA233259

NCI NIH HHS

Grant: P30 CA016058

NHLBI NIH HHS

Grant: U01 HL126496

Boehringer Ingelheim

Bristol-Myers Squibb

Kyowa Hakko Kirin

Uehara Memorial Foundation

Japanese Respiratory Society

Teva Pharmaceutical Industries

Novartis

Merck

Merck Sharp and Dohme

Takeda Pharmaceuticals U.S.A.

FWCI

3.44

Citation Percentile

0.9%

Influential Citations

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jto.org/article/S1556086420304676/pdf

BRONZEhttp://www.jto.org/article/S1556086420304676/pdf

publisherhttp://www.jto.org/article/S1556086420304676/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1556086420304676?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1556086420304676?httpAccept=text/plain

Fields of Study

Extracellular vesicles in diseaseNanoplatforms for cancer theranosticsMicroRNA in disease regulationMedicineBiology

MeSH Terms

Extracellular VesiclesCirculating MicroRNAAgedAged, 80 and overFemaleHumansLung NeoplasmsMaleMiddle AgedBiomarkers, TumorBiomarkersMicroRNAsB7-H1 AntigenProgrammed Cell Death 1 Receptor

Keywords

MedicinemicroRNAProgrammed cell deathMicrovesiclesApoptosisExtracellular vesiclesCancer researchLigand (biochemistry)Extracellular vesicleOncologyCell biologyInternal medicineReceptorBiochemistryGeneBiologyLung cancerAnti–pd-1Anti–pd-l1

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

10.6084/m9.figshare.19589139.v1figshare

Additional file 2 of miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

10.6084/m9.figshare.19589139figshare

Additional file 1 of Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study

10.6084/m9.figshare.26942466.v1figshare

Additional file 1 of Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study

10.6084/m9.figshare.26942466figshare

Additional file 1 of miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

10.6084/m9.figshare.19589133.v1figshare

Additional file 1 of miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

10.6084/m9.figshare.19589133figshare